About B. Lall Pharma Private Limited
Data last updated:
B. Lall Pharma Private Limited is a private limited company based in Delhi, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 01 April 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2020PTC363122. Its GSTIN is 07AAICB9745Q1ZS (Delhi).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹9 Lakh. It is led by directors including Rohit Mediratta and Sunil Mediratta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1581/3 – 4 Bhagirath Palace Chandani Chowk, Delhi, India – 110006.
As per the financials filed for FY 2025, the company reported a revenue of ₹21.04 Cr, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹31.92 Lakh (net margin 1.5%) and EBITDA of ₹48.83 Lakh (EBITDA margin 2.3%). Revenue has grown at a compounded annual rate (CAGR) of 42% over three years.
As per MCA filings, the company has open charges of ₹17 Lakh on record.
For more details, the company can be reached via its website blall.in.
Company details
Contact details
B. Lall Pharma Private Limited's registered office is in Delhi, Delhi. Its website is blall.in. Its e-mail address is in the company report.
- Email
- Website
- Registered Address1581/3 – 4 Bhagirath Palace Chandani Chowk, Delhi, India – 110006
- IndustryChemicals and Materials, Chemical Distribution & Retail
To see the full contact details of B. Lall Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of B. Lall Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of B. Lall Pharma Private Limited, buy the company report.
Financials of B. Lall Pharma Private Limited
FY 2025 filings availableB. Lall Pharma Private Limited reported revenue of ₹21.04 Cr (up 37% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 42% over three years, including 37% growth in the latest year. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹48.83 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹31.92 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.3% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of B. Lall Pharma Private Limited, buy the company report.
Board of directors of B. Lall Pharma Private Limited
B. Lall Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohit Mediratta | Director | 01 Apr 2020 | 6 Years 6 Months | Current |
| Sunil Mediratta | Director | 01 Apr 2020 | 6 Years 6 Months | Current |
| Anil Mediratta | Director | 01 Apr 2020 | 6 Years 6 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Dec 2022 | 100645561 | Others | ₹17 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving B. Lall Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for B. Lall Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
B. Lall Pharma Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
GST
B. Lall Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAICB9745Q1ZS | Delhi | Active | 14 Jun 2020 |
To see the full GST registrations and return filing status of B. Lall Pharma Private Limited, buy the company report.
Recent activity
B. Lall Pharma Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Anil Mediratta was appointed as Director on 01 Apr 2020.
Frequently asked questions
B. Lall Pharma is an active private limited company based in Delhi, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 01 April 2020 (6+ years old) and is registered under CIN U24230DL2020PTC363122.
B. Lall Pharma has 3 current directors:
- Rohit Mediratta - Director
- Sunil Mediratta - Director
- Anil Mediratta - Director
The latest financial statements of B. Lall Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of B. Lall Pharma is 07AAICB9745Q1ZS, registered in Delhi.
The CIN (Corporate Identification Number) of B. Lall Pharma is U24230DL2020PTC363122. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
B. Lall Pharma was incorporated on 01 April 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Anil Mediratta was appointed as Director on 01 Apr 2020. Rohit Mediratta was appointed as Director on 01 Apr 2020. Sunil Mediratta was appointed as Director on 01 Apr 2020.
B. Lall Pharma can be reached through the website blall.in. Its registered office is in Delhi, India.
The registered office of B. Lall Pharma is at 15813 – 4 Bhagirath Palace Chandani Chowk, Delhi, India – 110006.
B. Lall Pharma operates in the chemicals and materials industry, in the chemical distribution and retail segment.